SEC Form 4 · accession 0001493152-26-029849
FibroBiologics, Inc. · FBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Link
Director
Period of report
Jun 23, 2026
Accepted (ET)
Jun 23, 2026 · 8:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001958777
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.7503 | Jun 23, 2026 | A | 30,803 | A | — | Jun 22, 2036 | Common Stock | 30,803 | 30,803 | D |
Explanation of responses
- F1The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting.